Welcome and introductions (ID 4853)
A new era of next generation therapies in HER2-positive breast cancer (ID 4854)
Breakthrough developments in triple-negative breast cancer (ID 4856)
HR-positive breast cancer: emerging trends in cancer treatment (ID 4855)
Live panel discussion and Q&A (ID 4857)
